A first generation inhibitor of human Greatwall kinase, enabled by structural and functional characterisation of a minimal kinase domain construct

MASTL (microtubule-associated serine/threonine kinase-like), more commonly known as Greatwall (GWL), has been proposed as a novel cancer therapy target. GWL plays a crucial role in mitotic progression, via its known substrates ENSA/ARPP19, which when phosphorylated inactivate PP2A/B55 phosphatase. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Ocasio, Cory A., Rajasekaran, Mohan B., Walker, Sarah, Le Grand, Darren, Spencer, John, Pearl, Frances M.G., Ward, Simon E., Savic, Velibor, Pearl, Laurence H., Hochegger, Helfrid, Oliver, Antony W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342071/
https://www.ncbi.nlm.nih.gov/pubmed/27563826
http://dx.doi.org/10.18632/oncotarget.11511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342071/
https://www.ncbi.nlm.nih.gov/pubmed/27563826
http://dx.doi.org/10.18632/oncotarget.11511

Ejemplares similares